Resveratrol and vitamin E rescue valproic acid-induced teratogenicity: The mechanism of action

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 3, 2014, Pages 210-219

  Hsieh, Chiu Lan ^a   Chen, Kuan Chou ^b,c   Lin, Ping Xiao ^a   Peng, Chiung Chi ^d   Peng, Robert Y ^e  

^a NATIONAL CHANGHUA UNIVERSITY OF EDUCATION   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

ACC; Chicken embryo model; CPT1; Haemorrhagic liposis; Resveratrol; Valproic acid; Vitamin E

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALPHA TOCOPHEROL; CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; GLUTATHIONE; HOMOCYSTEINE; HYDROGEN PEROXIDE; INTERLEUKIN 6; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; S ADENOSYLHOMOCYSTEINE; TRIACYLGLYCEROL; VALPROIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; HEMORRHAGIC LIPOSIS; NECK MUSCLE; NEURAL TUBE DEFECT; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TERATOGENICITY; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ZYGOTE;

ACC; CHICKEN EMBRYO MODEL; CPT1; HAEMORRHAGIC LIPOSIS; RESVERATROL; VALPROIC ACID; VITAMIN E;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTIOXIDANTS; CHICK EMBRYO; GLUTATHIONE; REACTIVE OXYGEN SPECIES; STILBENES; TERATOGENESIS; VALPROIC ACID; VITAMIN E;

EID: 84896327721     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12205     Document Type: Article

References (35)

1. Kultima K, Nyström AM, Scholz B, Gustafson AL, Dencker L, Stigson M. Valproic acid teratogenicity: A toxicogenomics approach. Environ. Health Perspect. 2004; 112: 1225-35.
2. Hsieh CL, Wang HE, Tsai WJ, Peng CC, Peng RY. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model. Toxicology 2012; 291: 32-42.
3. Johannessen CU. Mechanisms of action of valproate: A commentatory. Neurochem. Int. 2000; 37: 103-11.
4. Mominoki K, Kinutani M, Wakisaka H, Saito S. Leg dysfunctions in a hatched chick model of spina bifida aperta. Exp. Neurol. 2006; 197: 133-42.
5. Tung EWT, Winn LM. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: A role for oxidative stress in valproic acid-induced neural tube defects. Mol. Pharmacol. 2011; 80: 979-87.
6. Lheureux PE, Penaloza A, Zahir S, Gris M. Science review: Carnitine in the treatment of valproic acid-induced toxicity: What is the evidence? Crit. Care 2005; 9: 431-40.
7. Menegola ED, Di Renzo F, Broccia ML, Giavini E. Inhibition of histone deacetylase as a new mechanism of teratogenesis. Birth Defects Res. C Embryo Today 2006; 78: 345-53.
8. van Gelder MMHJ, van Rooij IALM, Miller RK, Zielhuis GA, de Jong-van den Berg LTW, Roeleveld N. Teratogenic mechanisms of medical drugs. Hum. Reprod. Update 2010; 16: 378-94.
9. Aktas A, Nergiz Y, Akkus M. The effect of valproic acid on rat ovarium and the protective role of vitamin E and folic acid: An ultrastructural study. Afr. J. Biotechnol. 2010; 9: 5616-22.
10. Saleh AlD, Khalaf AlM, Mohammed A, Mohammed T. Vitamin E decreases valproic acid induced neural tube defects in mice. Neurosci. Lett. 2005; 292: 179-92.
11. Baran ÖP, Tunik S, Akkoc H, et al. The prophylactic effects of folic acid and vitamin E against valproic acid during fetal thymus development: An ultrastructural study. Int. J. Morphol. 2011; 29: 1093-8.
12. Fremont L. Biological effects of resveratrol. Life Sci. 2000; 66: 663-7.
13. Dong Z. Molecular mechanisms of the chemopreventive effect of resveratrol. Mutat. Res. 2003; 523: 145-50.
14. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006; 5: 493-506.
15. Bishayee A, Darvesh AS, Politis T, McGory R. Resveratrol and liver disease. From bench to bedside and community. Liver Int. 2010; 147: 1103-14.
16. Pascoe GA, Olafsdottir K, Reed DJ. Vitamin E protection against chemical-induced cell injury. I. Maintenance of cellular protein thiols as a cytoprotective mechanism. Arch. Biochem. Biophys. 1987; 256: 150-8.
17. Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo. J. Morphol. 1951; 88: 49-92.
18. Ker YB, Peng CC, Lin CH, Chen KC, Hsieh CL, Peng RY. In vitro polyphenolics erythrocyte model and in vivo chicken embryo model revealed gallic acid to be a potential hemorrhage inducer: Physicochemical action mechanisms. Chem. Res. Toxicol. 2013; 26: 325-35.
19. Castro R, Rivera I, Struys EA, et al. Increased homocysteine and s-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 2003; 49: 1292-6.
20. Zhao S, Ma H, Miao J, Zou S, Chen W. Effect of maternal rearing on lipid metabolism-related gene expression in offspring broilers during embryonic development. Br. Poult. Sci. 2010; 51: 500-6.
21. Chen KC, Chuang CM, Lin LY, et al. The polyphenolics in the aqueous extract of Psidium guajava kinetically reveal an inhibition model on LDL glycation. Pharm. Biol. 2010; 48: 23-31.
22. Jurima-Romet M, Abbott FS, Tang W, Huang HS, Whitehouse LW. Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathionedepleted rat hepatocytes. Toxicology 1996; 112: 69-85.
23. 2-induced oxidative damage in primary cultured rat hepatocytes. J. Agric. Food Chem. 2005; 53: 4182-6.
24. Yang H, Sung SH, Kim YC. Two new hepatoprotective stilbene glycosides from Acer mono leaves. J. Nat. Prod. 2005; 68: 101-3.
25. Rubiolo JA, Mithieux G, Vega FV. Resveratrol protects primary rat hepatocytes against oxidative stress damage: Activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur. J. Pharmacol. 2008; 591: 66-72.
26. Han D, Canali R, Rettori D, Kaplowittz N. Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria. Mol. Pharmacol. 2003; 64: 1136-44.
27. You BR, Kim SH, Park WH. Gallic acid-induced lung cancer cell death is accompanied by ROS increase and glutathione depletion. Mol. Cell. Biochem. 2011; 357: 295-303.
28. Shiah IS, Lin Y, Yeh CB, Ravindran AV. Effect of valproate on plasma levels of interleutin-6 in healthy male humans. Int. Clin. Psychopharmacol. 2005; 20: 295-8.
29. Al-Shanti N, Saini A, Stewart C. Controversial interactions between TNF-alpha and IL-6 in C2 skeletal myoblast cell death. Endocrine Abstr. 2007; 13: 123.
30. van der Put NM, Blom HJ. Neural tube defects and a disturbed folate dependent homocysteine metabolism. Eur. J. Obstet. Gynecol. Reprod. Biol. 2000; 92: 57-61.
31. Úbeda N, Alonso-Aperte E, Varela-Moreiras G. Acute valproate administration impairs methionine metabolism in rats. J. Nutr. 2002; 132: 2737-42.
32. Aires CCP, Ijlst L, Stet F, et al. Inhibition of hepatic carnitine palmitoyl-transferase-1 (CPT1) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochem. Pharmacol. 2010; 79: 792-9.
33. Ruderman NB, Dean D. Malonyl CoA, long chain fatty acyl CoA and insulin resistance in skeletal muscle. J. Basic Clin. Physiol. Pharmacol. 1998; 9: 295-308.
34. Chuang CM, Chang CH, Wang HE, et al. Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis: A kinetic analysis on retinol/retinoic acid homeostatic system. PLoS ONE 2012; 7: e43692.
35. Deeb SA, Moutaery KA, Arshaduddin M, Tariq M. Vitamin E decreases valproic acid induced neural tube defects in mice. Neurosci. Lett. 2000; 292: 179-82.